RayzeBio, Inc. Common Stock
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has RayzeBio, Inc. Common Stock's balance sheet done over the years? Its assets were worth $324,776,000 last year, which is more than in the previous period. 134% of RayzeBio, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $436,070,000, which means an increase by 61% compared compared to last year.
Debt to Assets
| 2020 | 148449000 | 151.28M | 101.91% |
|---|---|---|---|
| 2021 | 216385000 | 270.95M | 125.22% |
| 2022 | 324776000 | 436.07M | 134.27% |
RYZB Balance Sheet (2020 – 2022)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
Assets | |||
Current assets: | |||
Cash and cash equivalents | 129.15M | 50.56M | 143.72M |
Short term investments | 167.08M | 148.6M | 3.14M |
Net receivables | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 |
Other current assets | 3.79M | 3.26M | 211K |
Total current assets | 300.03M | 202.42M | 147.08M |
Non-current assets: | |||
Property, Plant and Equipment | 24.39M | 13.57M | 1.23M |
Goodwill | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 |
Other non-current assets | 347K | 385K | 135K |
Total non-current assets | 24.73M | 13.95M | 1.36M |
Total assets | 324.77M | 216.38M | 148.44M |
Liabilities | |||
| Current liabilities: | |||
Accounts payable | |||
Deferred revenue | 0 | 0 | 0 |
Short term debt | 1.14M | 1.84M | 763K |
Total current liabilities | 10.45M | 6.13M | 1.50M |
| Non-current liabilities: | |||
Long term debt | 9.42M | 7.20M | 0 |
Deferred tax | 0 | 0 | 0 |
Other non-current liabilities | 416.18M | 257.61M | 149.77M |
Total non-current liabilities | 425.61M | 264.82M | 149.77M |
Total liabilities | 436.07M | 270.95M | 151.28M |